The cost-effectiveness of isavuconazole compared to voriconazole, the standard of care in the treatment of patients with invasive mould diseases, prior to differential pathogen diagnosis in Spain

  1. Azanza, J.R.
  2. Grau, S.
  3. Vázquez, L.
  4. Rebollo, P.
  5. Peral, C.
  6. López-Ibáñez de Aldecoa, A.
  7. López-Gómez, V.
Journal:
Mycoses

ISSN: 1439-0507 0933-7407

Year of publication: 2021

Volume: 64

Issue: 1

Pages: 66-77

Type: Article

DOI: 10.1111/MYC.13189 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals